Results 1 to 10 of about 74,576 (156)
Asciminib for Philadelphia chromosome positive leukemias [PDF]
HaematologicaTwenty-five years after the introduction of imatinib, we have entered a new era of therapy for Chronic Myeloid Leukemia (CML). Despite the development of second and third generation (2G and 3G) tyrosine kinase inhibitors (TKIs), their impact have been ...
Timothy P. Hughes +2 more
doaj +2 more sources
The Philadelphia chromosome in leukemogenesis [PDF]
Chinese Journal of Cancer, 2016 The truncated chromosome 22 that results from the reciprocal translocation t(9;22)(q34;q11) is known as the Philadelphia chromosome (Ph) and is a hallmark of chronic myeloid leukemia (CML).
Zhi-Jie Kang +10 more
doaj +3 more sources
Gomal Journal of Medical Sciences, 2017 Philadelphia (Ph’) chromosome is an abnormally short chromosome 22 formed as a result of translocation between chromosome 9 and 22. As a result the ABL gene from chromosome 9 joins the BCR gene on chromosome 22.
Habibullah Khan
doaj +1 more source
Asian Pacific Journal of Cancer Care, 2021 Background and Purpose: Chronic Myeloid Leukemia (CML) is a common hematological malignancy. The characteristic molecular abnormality is the presence of Philadelphia chromosome or BCR-ABL fusion gene which is the result of 9:22 translocation.
Shafaq Maqsood +3 more
doaj +1 more source
Turkish Journal of Hematology, 2010 We report herein a very rare case of acute lymphoblastic leukemia having a chromosomal constitution of 48,XY,+X,+5,t(9;22)(q34;q11) in the bone marrow.
Burak Durmaz +5 more
doaj +3 more sources
JAK2-V617F Mutation Combined with Philadelphia Chromosome-Positive Chronic Myeloid Leukaemia: a Case Report [PDF]
International Journal of Hematology-Oncology and Stem Cell Research, 2011 Myeloproliferative neoplasms (MPNs) such as polycythemia vera, essential thrombocythemia, primary myelofibrosis and chronic myeloid leukemia have too similar and accurate way to differentiate their is study of genetic disorders in these patients ...
Mehrdad Payande +3 more
doaj +1 more source
Revista Brasileira de Hematologia e Hemoterapia, 2015 Background: Chronic myeloid leukemia is a myeloproliferative disorder characterized by the Philadelphia chromosome or t(9;22)(q34.1;q11.2), resulting in the break-point cluster regionAbelson tyrosine kinase fusion gene, which encodes a constitutively ...
Maria de Lourdes Lopes Ferrari Chauffaille +2 more
doaj +1 more source
International Journal of Medical Students, 2015 Background: Treatment for adult Philadelphia chromosome+ acute lymphoblastic leukemia includes using dasatinib, a tyrosine kinase inhibitor. Cutaneous squamous cell carcinomas and keratoacanthomas are common findings in patients treated with BRAF ...
Siddhant Thukral +3 more
doaj +1 more source
Haematologica, 2019 Clonal chromosome abnormalities in Philadelphia-negative cells could concern chronic myeloid leukemia patients treated by tyrosine kinase inhibitors. The European LeukemiaNet distinguishes -7/del(7q) abnormalities as a “warning”.
Audrey Bidet +32 more
doaj +1 more source
Frontiers in Genetics, 2022 We aim to determine the spectrum of cytogenetic abnormalities and outcomes in unbalanced offspring of asymptomatic constitutional balanced t(9;22) carriers through a systematic literature review. We also include a case of a constitutional balanced t(9;22)
Zimeng Gao +8 more
doaj +1 more source